← 홈

전체 프로그램

ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 4,162개
ADCABiologicRocheDM1) and trastuzumab deruxt…Phase 3

ado-trastuzumab emtansine (Kadcyla, T-DM1)

Breast Cancer · Breast Cancer

#BreastCancer#ADC#Phase3#인기#항체약물접합체+4
효능 ORR 80%임상시험 76상태 RECRUITING
ADCCBiologicOrtho Biotech, Inc.Phase 2

polymorphism analysis (polymorphism analysis)

Prostatic Neoplasms · Adult Lymphocyte Depletion Hodgkin Lymph

#AdultLymphocyteDepletionHodgkinL#ADC#Phase2#인기#항체약물접합체+3
효능 ORR 47.5%임상시험 76상태 ACTIVE
ADCBBiologicSuzhou Transcenta Therapeutics …Govitecan in Untreated, Adv…Phase 2

Albumin-bound paclitaxel (Albumin-bound paclitaxel)

Advanced Cancer; Gastric Cancer · Solid Cancer

#SolidCancer#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 63.5%임상시험 75상태 RECRUITING
ADCBBiologicSeagenvedotin and the anti-HER2 t…Preclinical

Genetical Recombination (Brentuximab Vedotin, Brentuximab Vedotin (Genetical Recombination))

Untreated CD30-Positive Hodgkin's Lymphoma · Peripheral T Cell Lymphoma

#PeripheralTCellLymphoma#ADC#Preclinical#인기#항체약물접합체+5
효능 ORR 91.7%임상시험 75상태 ACTIVE
ADCCBiologicOHSU Knight Cancer InstitutePhase 2

Niraparib (Niraparib)

Advanced Breast Carcinoma; Advanced Malignant Solid Neoplasm · Advanced Breast Carcinoma

#AdvancedBreastCarcinoma#ADC#Phase2#인기#항체약물접합체+3
효능 ORR 88%임상시험 75상태 DISCONTINUED
ADCABiologicSeagenVedotin: A Retrospective Co…Phase 2

BV (Induction with Brentuximab vedotin, Induction with Brentuximab vedotin (BV))

Hodgkin Lymphoma, Adult · Hodgkin Lymphoma, Adult

#HodgkinLymphomaAdult#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 78.3%임상시험 74상태 RECRUITING
ADCCBiologicBristol-Myers SquibbDM4, indicating activation …Phase 2

Vemurafenib (Vemurafenib)

Metastatic Thyroid Gland Carcinoma; Poorly Differentiated Thyroid Gland Carcinoma · Advanced Breast Carcinoma

#AdvancedBreastCarcinoma#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 94%임상시험 74상태 DISCONTINUED
CGTABiologicNational Cancer Institute (NCI)inPhase 1

Anti-B Cell Maturation Antigen (BCMA, Anti-B Cell Maturation Antigen, Anti-B Cell Maturation Antigen (BCMA) chimeric antigen receptors (CARs) T cells)

Myeloma-Multiple; Myeloma, Plasma-Cell · BCMA

#BCMA#CGT#Phase1#인기#세포유전치료+5
효능 ORR 97.1%임상시험 73상태 RECRUITING
CGTBBiologicBioceltech Therapeutics, Ltd.Phase 1

CD19 CAR T cells (CD19 CAR T cells)

B-cell Acute Lymphoblastic Leukemia · CD19

#CD19#CGT#Phase1#인기#세포유전치료+5
효능 ORR 88%임상시험 73상태 RECRUITING
ADCBBiologicMerck Sharp & Dohme LLCPhase 2

Cytoxan (Cytoxan)

Multiple Myeloma, Refractory · Metastatic Breast Cancer

#MetastaticBreastCancer#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 95%임상시험 73상태 RECRUITING
AntibodyCNovartis PharmaceuticalsApproved

Abatacept (Abatacept)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Approved#인기#항체+4
효능 ORR 6.35%임상시험 72상태 ACTIVE
ADCBBiologicActinium PharmaceuticalsreleasePhase 2

Daunorubicin (Daunorubicin)

Acute Leukemia of Ambiguous Lineage; B Acute Lymphoblastic Leukemia · Leukemia

#Leukemia#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 95%임상시험 72상태 RECRUITING
AntibodyCMiltenyi Biomedicine GmbHPhase 3

Alemtuzumab (Alemtuzumab)

Leukemia; Lymphoma · Fanconi Anemia

#FanconiAnemia#Antibody#Phase3#인기#항체+5
효능 ORR 33%임상시험 71상태 DISCONTINUED
ADCABiologicPalleos Healthcare GmbHderuxtecan in a patient wit…Phase 3

Liposomal doxorubicin (Liposomal doxorubicin)

Lymphoproliferative Disorder; HHV-8 · Breast Neoplasms

#BreastNeoplasms#ADC#Phase3#인기#항체약물접합체+5
효능 ORR 95%임상시험 71상태 RECRUITING
ADCBBiologicTheRas, Inc., dPhase 2

mFOLFOX6 (mFOLFOX6)

Non-Small Cell Lung Cancer; NSCLC · HER2

#HER2#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 63.64%임상시험 71상태 RECRUITING
ADCBiologicPalleos Healthcare GmbHvedotin, vinblastine, and d…Phase 2

Adriamycin (Adriamycin)

Multiple Myeloma · Hodgkin Lymphoma

#HodgkinLymphoma#ADC#Phase2#인기#항체약물접합체+4
효능 ORR 95%임상시험 70상태 ACTIVE
AntibodyCSanofiPhase 3

REGN668 (Dupilumab SAR231893, Dupilumab SAR231893 (REGN668))

Prurigo Nodularis · Dermatitis Atopic

#DermatitisAtopic#Antibody#Phase3#인기#항체+5
효능 ORR 0.45%임상시험 70상태 ACTIVE
ADCSBiologicShanghai Juncell TherapeuticsApproved

Hydroxychloroquine (Hydroxychloroquine)

Psoriasis; Atopic Dermatitis · Advanced Breast Cancer

#AdvancedBreastCancer#ADC#Approved#인기#항체약물접합체+4
효능 ORR 75%임상시험 70상태 ACTIVE
ADCCBiologicSunnybrook Health Sciences Cent…Phase 3

Imatinib (Imatinib)

COVID-19 · ALK+ Anaplastic Large Cell Lymphoma

#ALK+AnaplasticLargeCellLymphoma#ADC#Phase3#인기#항체약물접합체+3
효능 ORR 54.5%임상시험 70상태 DISCONTINUED
AntibodyBristol Myers SquibbPhase 2

nivolumab (Opdivo, Nivolumab & Ipilimumab)

Carcinoma, Renal Cell; Clear-cell Metastatic Renal Cell Carcinoma · Prostate Cancer

#ProstateCancer#Antibody#Phase2#인기#항체+5
효능 ORR 61.3%임상시험 70상태 ACTIVE

8 / 209 페이지

← 이전다음 →